|
April 26, 2021
|
Progenity to Present Two Abstracts for Novel Ingestible Drug Delivery Technologies at Digestive Disease Week 2021
|
|
April 8, 2021
|
Progenity to Present Key Prospective Verification Study Data for its Preeclampsia Rule-Out Test at 2021 American College of Obstetricians and Gynecologists Annual Meeting
|
|
April 6, 2021
|
Progenity and Ionis Pharmaceuticals Enter into Agreement to Evaluate Progenity’s Ingestible Oral Biotherapeutics Technology for Delivery of Antisense Therapies
|
|
March 18, 2021
|
Progenity Provides Corporate Updates and Reports Fourth Quarter and Full-Year 2020 Financial Results
|
|
March 12, 2021
|
Progenity to Report Fourth Quarter and Full Year 2020 Financial Results and Provide Corporate Update
|
|
February 23, 2021
|
Progenity Announces $25 Million Private Placement
|
|
February 17, 2021
|
Progenity Initiates Safety and Tolerability Study of its Smart Capsule-Based Oral Drug Delivery System for GI Diseases
|
|
February 12, 2021
|
SMFM Conference and Publications Highlight the Challenges and Complexities of Diagnosing and Managing Preeclampsia
|
|
February 10, 2021
|
Progenity to Participate in Two Upcoming Investor Conferences
|
|
January 20, 2021
|
Progenity Reaches Two Million Test Milestone
|